Page last updated: 2024-08-26

cilastatin and Soft Tissue Infections

cilastatin has been researched along with Soft Tissue Infections in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	4 (57.14)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, LY; Gong, YL; Huang, GT; Jiang, B; Peng, YZ; Yang, ZC; Yin, SP	1
Butivshchenko, IA; Goriunov, SV; Il'ianina, AA; Mikhal'skiĭ, VV; Polikarpova, SV; Rog, AA; Romashov, DV	1
Embil, JM; Fabian, TC; File, TM; Klein, S; Krige, JE; Melnick, D; Rose, A; Soto, NE	1
Kuti, JL; Nicolau, DP; Ong, CT	1
Embil, JM; Melnick, DA; Soto, NE	1
Geckler, RW; Nichols, RL; Smith, JW; Wilson, SE	1
Bolash, NK; Liu, HH; Lynch, RA; McAnany, ME	1

Trials

5 trial(s) available for cilastatin and Soft Tissue Infections

Article	Year
[Efficacy of imipenem-cilastatin in combined therapy of severe anaerobic-aerobic infection of bones and soft tissues]. Khirurgiia, 2002, Issue:7 Topics: Adult; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bone Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Severity of Illness Index; Soft Tissue Infections	2002
Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study. Surgical infections, 2005,Fall, Volume: 6, Issue:3 Topics: Adolescent; Adult; Aged; Bacteria, Anaerobic; Cilastatin; Cilastatin, Imipenem Drug Combination; Double-Blind Method; Drug Combinations; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Meropenem; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Thienamycins; Treatment Outcome	2005
A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus. Clinical therapeutics, 2006, Volume: 28, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetes Complications; Double-Blind Method; Drug Combinations; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Thienamycins	2006
Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections. Southern medical journal, 1995, Volume: 88, Issue:4 Topics: Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cellulitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Infusions, Intravenous; Male; Meropenem; Middle Aged; Prospective Studies; Skin Diseases, Infectious; Soft Tissue Infections; Thienamycins; Ulcer	1995
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin. Drugs, 1995, Volume: 49 Suppl 2 Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections	1995

Other Studies

2 other study(ies) available for cilastatin and Soft Tissue Infections

Article	Year
[Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice]. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2016, Sep-20, Volume: 32, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteriophages; Burns; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Liver; Mice; Mice, Inbred BALB C; Random Allocation; Sepsis; Soft Tissue Infections; Stem Cells	2016
Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program. Surgical infections, 2005,Winter, Volume: 6, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Population Surveillance; Prevalence; Soft Tissue Infections; Thienamycins	2005

Article

Year

[Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].

Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2016, Sep-20, Volume: 32, Issue:9

Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteriophages; Burns; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Liver; Mice; Mice, Inbred BALB C; Random Allocation; Sepsis; Soft Tissue Infections; Stem Cells

2016

Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.

Surgical infections, 2005,Winter, Volume: 6, Issue:4

Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Population Surveillance; Prevalence; Soft Tissue Infections; Thienamycins

2005